Cargando…

Linked HIV/SARS-CoV-2 testing could reduce incidence of HIV and costs

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596313/ https://www.ncbi.nlm.nih.gov/pubmed/33144828 http://dx.doi.org/10.1007/s40274-020-7247-x

Ejemplares similares

Could veterinarians be immune to contracting SARS-CoV-2?
por: Kozłowska-Geller, Monika Anna, et al.
Publicado: (2022)

Expanded testing for COVID-19 could be cost effective in USA
Publicado: (2020)

Oral HIV self-test kit distribution cost effective in South Africa?
Publicado: (2021)

Assessment of SARS-CoV-2 in the Cerumen of COVID-19-Positive Patients
por: Islamoglu, Yuce, et al.
Publicado: (2021)

Rapid Diagnostic Testing for SARS-CoV-2
por: Drain, Paul K.
Publicado: (2022)

Could SARS-CoV-2 cause tauopathy?
por: Pratt, James, et al.
Publicado: (2021)

Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections?
por: Sampson, Victoria, et al.
Publicado: (2020)

Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV
por: Shahbaz, Shima, et al.
Publicado: (2023)

Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia
por: Taus, Francesco, et al.
Publicado: (2020)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Incidence and severity of SARS-CoV-2 infection in children and young people with HIV in Europe
Publicado: (2023)

Could SARS-CoV-2 be associated with emphysematous gastritis?
por: Garrosa-Muñoz, Sonsoles, et al.
Publicado: (2021)

Could the stethoscope be a SARS-CoV-2 vector?
por: Baeza-Trinidad, Ramón, et al.
Publicado: (2022)

Could the stethoscope be a SARS-CoV-2 vector?
por: Baeza-Trinidad, Ramón, et al.
Publicado: (2022)

HIV and SARS-CoV-2 Co-Infection: What are the Risks?
por: Squillace, Nicola, et al.
Publicado: (2021)

Molecular epidemiology in the HIV and SARS-CoV-2 pandemics
por: Lorenzo-Redondo, Ramon, et al.
Publicado: (2021)

Similarities and differences between HIV and SARS-CoV-2
por: Illanes-Álvarez, Francisco, et al.
Publicado: (2021)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

Temperature in Nursing Home Residents Systematically Tested for SARS-CoV-2
por: Rudolph, James L., et al.
Publicado: (2020)

Incidence and Outcomes of SARS-CoV-2 in Post-Acute Skilled Nursing Facility Care
por: Ritter, Ashley Z., et al.
Publicado: (2022)

Information and Communication Technology to Link Criminal Justice Reentrants to HIV Care in the Community
por: Kurth, Ann, et al.
Publicado: (2013)

The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era
por: Al-Obaidi, Mohanad M., et al.
Publicado: (2023)

Incident SARS-CoV-2 Infection and a Shared Latrine
por: Del Brutto, Oscar H., et al.
Publicado: (2020)

The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
por: Henke, Wyatt, et al.
Publicado: (2022)

The Envelope Proteins from SARS-CoV-2 and SARS-CoV Potently Reduce the Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)
por: Henke, Wyatt, et al.
Publicado: (2022)

HIV-1 Replication in HIV-Infected Individuals Is Significantly Reduced When Peripheral Blood Mononuclear Cells Are Superinfected with HSV-1
por: Yamsuwan, Taneth, et al.
Publicado: (2012)

Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
por: McMahan, Katherine, et al.
Publicado: (2022)

Could SARS-CoV-2 be transmitted via speech droplets?
por: Anfinrud, Philip, et al.
Publicado: (2020)

Could the SARS-CoV-2 infection be acquired from Smartphones?
por: Law, Siukan, et al.
Publicado: (2020)

Oral Mucosa Could Be an Infectious Target of SARS-CoV-2
por: Okui, Tatsuo, et al.
Publicado: (2021)

Could the SARS-CoV-2 Infection be Acquired via the Eye?
por: Law, Siukan, et al.
Publicado: (2021)

Could Endogenous Glucocorticoids Influence SARS-CoV-2 Infectivity?
por: Hardy, Eugenio, et al.
Publicado: (2022)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?
por: Mitchell, Kate M., et al.
Publicado: (2018)

Patterns of HIV and SARS‐CoV‐2 co‐infection in Wuhan, China
por: Guo, Wei, et al.
Publicado: (2020)

SARS‐CoV‐2, HIV, and Mycobacterium tuberculosis triple co‐infection
por: Ngouanom Kuate, Marius Paulin, et al.
Publicado: (2022)

Programmed ribosomal frameshifting in HIV-1 and the SARS–CoV
por: Brierley, Ian, et al.
Publicado: (2006)

Antibody response to SARS-CoV-2 in people living with HIV
por: Yamamoto, Shinya, et al.
Publicado: (2021)

SARS-CoV-2 immunity and HIV infection: total recall?
por: Dauby, Nicolas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vlfr31fn3eivnap0d0b369sltt